Last reviewed · How we verify
NCT04858945: TB
Using Teach Back to Improve Postpartum Maternal-infant Health Among Women With Limited Maternal Health Literacy
NA trial testing Teach-back method in Pregnant Women in 258 participants. Completed in 12 September 2021.
10 August 2021
Quick facts
| Lead sponsor | Anhui Provincial Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 258 |
| Start date | 17 May 2021 |
| Primary completion | 10 August 2021 |
| Estimated completion | 12 September 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Teach-back method
Conditions studied
- Pregnant Women — all drugs for Pregnant Women →
Sponsor
Anhui Provincial Hospital
Who can join
18 and older, female only, with Pregnant Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized controlled trial study with two arms teach-back group vs. controlled group. We decided the assignment of the women to each group by tossing a coin (heads for the teach-back group and tails for the control group). The women were informed about receiving education during the trial, but they were not aware of the forms and techniques used in the trial, nor were they aware if they were assigned to the teach-back group or control group. For the first two education sessions, the women were grouped based on the time of their recruitment, i.e., being the first recruited, being the first grouped and being the first to receive education. The educators were numbered from 1 to 8 according to their work shifts and were assigned to education sessions in sequence and cycle. For the third education session, the educators were assigned to contact women based on the matching of their work schedules. The women could be grouped with different peers and met different educators during the trial. In this way, we could reduce the possible influence of educators and group peers on the results of the trial.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Using the teach-back method to improve postpartum maternal-infant health among women with limited maternal health literacy: a randomized controlled study.
Cheng GZ, Chen A, Xin Y, Ni QQ. · · 2023 · cited 20× · PMID 36624440 · DOI 10.1186/s12884-022-05302-w
Verify or expand the search:
- PubMed search for NCT04858945
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pregnant Women
Currently open trials in the same condition.
- NCT07238608 — Impact of UFPs and MNPs on Fetal Health · recruiting
- NCT06976632 — Effect of Helfer Skin Tap and Cold Application on Pain and Hemodynamics During Vaccination · NA · recruiting
- NCT07084103 — Effectiveness of a Psychosocial Support Intervention for Women Diagnosed With Fetal Anomaly · NA · recruiting
- NCT07258329 — Screening for Intrapartum Fetal Compromise Using Placental Biomarkers · recruiting
- NCT07058766 — Development of Post-Disaster Care Protocol for Pregnant Women and Evaluation of Its Effectiveness · NA · recruiting
Other Anhui Provincial Hospital trials
Trials by the same sponsor.
- NCT07523464 — Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC · Phase 1 · not yet recruiting
- NCT07481656 — Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT) · Phase 4 · not yet recruiting
- NCT07462676 — Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT. · NA · not yet recruiting
- NCT07211048 — Anti CD19 Gene Therapy for B-cell Lymphoma · NA · recruiting
- NCT07279844 — An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04858945 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anhui Provincial Hospital
- Last refreshed: 2 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04858945.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing